Intravacc, a global leader in translational research and development of therapeutic vaccines and vaccines against infectious diseases, today announced a partnership with Dutch Leiden University Medical Center (LUMC) to develop and evaluate a new nasal spray corona vaccine in a clinical phase I/II study.
Leiden University Medical Center and Intravacc to start clinical trial with new intranasal corona vaccine
January 5, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022